Rare mutations tied to breast, pancreatic cancers

Mutations in genes that fix mismatched DNA may put people at extra risk for breast cancer and pancreatic cancer, in addition to their well-known ties to colon and endometrial cancers, a new report suggests

Rare mutations tied to breast, pancreatic cancers: study

NEW YORK (Reuters Health) - Mutations in genes that fix mismatched DNA may put people at extra risk for breast cancer and pancreatic cancer, in addition to their well-known ties to colon and endometrial cancers, a new report suggests. But close relatives of people with the inherited mutations, known collectively as Lynch syndrome, don't seem to have any extra cancer risk if they test negative ...

Triple Analysis: Breast Cancer, Pancreatic Cancer and Angiogenesis

NEW YORK, Feb. 6, 2012  /PRNewswire/ --  Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Breast Cancer, Pancreatic Cancer and Angiogenesis http://www.reportlinker.com/p0284795/Triple-Analysis-Breast-Cancer-Pancreatic-Cancer-and-Angiogenesis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=PathologyThis ...

Research and Markets: Metastatic Pancreatic Cancer - Pipeline Review, H1 2012

Research and Markets has announced the addition of Global Markets Direct's new report "Metastatic Pancreatic

Diabetes drugs tied to pancreatic cancer risk

NEW YORK (Reuters Health) - A new study links the diabetes drug metformin to fewer cases of pancreatic cancer -- at least in women -- but finds other diabetes medications are associated with a higher risk of the disease. The differences in medication history among people who did or didn't get pancreatic cancer were small, researchers said, and it's unclear why the drugs might affect cancer risks ...